Assessment of Diabetes-Related Complications and Its Association with Treatment Adherence among Type 2 Diabetes Patients in Rural Banda: A Community-Based Cross-Sectional Study

Article Sidebar

Published: 02/09/2026
DOI: https://doi.org/10.58999/j3r91g40

Main Article Content

Rahul Shrivastav
a:1:{s:5:"en_US";s:54:"Junior Resident , Rani Durgavati Medical College,Banda";}
Lal Divakar Singh
Mohd. Maroof
Suneel Kumar Kaushal
Shailendra Singh Chaudhary

Abstract

Background: Diabetes mellitus is a major public health problem, particularly in rural India where delayed diagnosis and poor treatment adherence contribute to complications. Quantifying complication burden using standardized scoring systems and understanding its association with adherence is essential. Objectives: To estimate the prevalence of diabetes-related complications among known diabetic patients using the Diabetes Complication Severity Score (DCSS) and to determine the association between treatment adherence and diabetes-related complications. Methods: A community-based cross-sectional study was conducted among 380 known type 2 diabetes mellitus patients in rural Banda district. Data were collected using a pre-tested questionnaire. Diabetes complications were assessed using a structured checklist to compute a complication severity score. Treatment adherence was measured using the Morisky Medication Adherence Scale (MMAS-8). Statistical analysis included descriptive statistics and chi-square test. Results: The prevalence of diabetes-related complications was 79.5%. A significant proportion of patients had multiple complications. Low adherence was observed in 56.3% of participants. A statistically significant association was found between poor adherence and higher complication burden (p < 0.05). Conclusion: Poor treatment adherence is significantly associated with increased complication severity. Strengthening adherence strategies can reduce diabetes-related morbidity.


Keywords: Diabetes Complication Severity Score, Treatment Adherence, T2DM, Rural Health, MMAS-8


 

Article Details

Issue

Online First 2026

Section

Original Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Assessment of Diabetes-Related Complications and Its Association with Treatment Adherence among Type 2 Diabetes Patients in Rural Banda: A Community-Based Cross-Sectional Study. (2026). Central India Journal of Medical Research. https://doi.org/10.58999/j3r91g40

References

1.International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.

2.World Health Organization. Global Report on Diabetes. Geneva: World Health Organization; 2016.

3.American Diabetes Association. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Suppl 1):S17–S38.

4.Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in India (ICMR-INDIAB study). Lancet Diabetes Endocrinol. 2017;5(8):585–596.

5.Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes in India: Current scenario and future perspectives. Indian J Med Res. 2016;143(6):685–695.

6.Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77–82.

7.World Health Organization. Prevention of Diabetes Complications. Geneva: WHO; 2016.

8.Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: A global systematic review. Diabetologia. 2015;58(6):1151–1163.

9.Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. J Assoc Physicians India. 2011;59:564–566.

10.Joshi SR, Parikh RM. India—diabetes capital of the world: Now heading towards hypertension. J Assoc Physicians India. 2015;63(10):16–20.

11.Gupta R, Misra A. Type 2 diabetes in India: Regional disparities. Indian Heart J. 2018;70(4):531–536.

12.Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. J Diabetes Sci Technol. 2015;9(2):403–408.

13.Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ. 2000;321(7258):405–412.

14.Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, et al. Diabetes Complication Severity Index and risk of mortality. Am J Manag Care. 2008;14(1):15–21.

15.Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.

16.Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality. Circulation. 2006;113(24):3028–3035.

17.Jimmy B, Jose J. Patient medication adherence: Measures in daily practice. Oman Med J. 2011;26(3):155–159.

18.Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314.

19.Venkatesan M, Dongre AR, Ganapathy K. A community-based study on medication adherence among diabetes patients in rural India. J Family Med Prim Care. 2020;9(7):3559–3564.

20.Viswanathan V, Tilak P, Kumpatla S. Prevalence of vascular complications among diabetic patients in South India. J Assoc Physicians India. 2019;67(3):25–29.

21.Shivashankar R, Mani G, Pradeepa R, et al. Burden of diabetes and its complications in rural Karnataka. Indian J Endocrinol Metab. 2015;19(4):548–552.

22.Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards diabetes control: Key issues. Int J Diabetes Dev Ctries. 2016;36(1):1–5.

23.Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222.

24.Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 1984;102(4):520–526.

25.Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in diabetes (Steno-2 Study). N Engl J Med. 2003;348(5):383–393.

26.Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in India. Indian J Ophthalmol. 2005;53(3):171–175.

27.Pradeepa R, Mohan V. Prevalence of complications in diabetes in India. J Assoc Physicians India. 2014;62(6):36–40.

28.Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering (ACCORD trial). N Engl J Med. 2008;358(24):2545–2559.

29.Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes. J Clin Diagn Res. 2013;7(1):1–3.

30.Bhandari S, Kharel S, Banjara MR. Medication adherence among diabetic patients. J Assoc Physicians India. 2015;63(7):42–45.

31.Goyal A, Jindal S, Rani S. Medication adherence and glycaemic control among diabetes patients. Indian J Endocrinol Metab. 2018;22(5):593–597.

32.Basu S, Garg S, Sharma N. Adherence to diabetes treatment in India. Indian J Public Health. 2019;63(4):289–294.

33.Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of adherence and mortality in chronic disease. BMJ. 2006;333(7557):15.